MeSH D016480 - helicobacter pylori
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Phathom Pharmaceuticals | Amoxicillin, Vonoprazan | Voquezna Dual | 2028-08-11 | 2022-05-03 |  |  |
| Amoxicillin, Clarithromycin, Vonoprazan | Voquezna Triple | 2028-08-11 | 2022-05-03 |  |  | |
| Vonoprazan | Voquezna | 2028-08-11 | 2023-11-01 | $1.9 M | Y2024 |
Clinical Trials
Historical Success Rate
Phase 1
100%8/8
Phase 2
0%0/0
Phase 3
100%7/7
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use